Online citations, reference lists, and bibliographies.

Controversies In Surgery For Pancreatic Cancer

H. Ramesh, J. Mathew, J. Manipadam, S. Galodha
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Pancreatic cancer continues to be a life-threatening disease with poor long term outcomes despite various treatments. Progress has been slow, although results of surgery have improved, and mortality rates have fallen. Surgery is still the modality with the highest potential to cure pancreatic cancer. We examine some of the key issues relating to the treatment of pancreatic cancer, largely to the description of issues related to pancreatic head cancer.
This paper references
10.1097/SLA.0b013e318156eef3
Long-term Survival and Metastatic Pattern of Pancreatic and Periampullary Cancer After Adjuvant Chemoradiation or Observation: Long-term Results of EORTC Trial 40891
H. Smeenk (2007)
10.1097/SLA.0000000000001808
Impact of Intraoperative Re-resection to Achieve R0 Status on Survival in Patients With Pancreatic Cancer: A Single-center Experience With 483 Patients
Philipp Nitschke (2017)
10.1097/MPA.0b013e31818166e6
Nerve Plexus Invasion in Pancreatic Cancer: Spread Patterns on Histopathologic and Embryological Analyses
I. Makino (2008)
10.1016/j.pan.2015.10.013
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer.
Kyoichi Takaori (2016)
10.1016/S1499-3872(15)60417-9
The "meso" of the rectum and the "meso" of the pancreas: similar terms but distinct concepts in surgical oncology.
N Peparini (2015)
10.1097/SLA.0b013e3181ad657b
Multivisceral Resection for Pancreatic Malignancies: Risk-Analysis and Long-Term Outcome
W. Hartwig (2009)
10.1002/bjs.1800811126
Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head
J. H. Allema (1994)
10.1097/SLE.0000000000000228
Comparison Between Minimally Invasive and Open Pancreaticoduodenectomy: A Systematic Review
C. Doula (2016)
10.1111/j.1477-2574.2012.00561.x
An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment.
V. Maksymov (2013)
10.1097/00000658-199905000-00003
Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome.
C. Yeo (1999)
10.3322/caac.21332
Cancer statistics, 2016
Rebecca L. Siegel Mph (2016)
10.1016/j.ejso.2014.01.010
Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis.
X. Yu (2014)
10.1097/00006676-200410000-00002
Desmoplastic Reaction in Pancreatic Cancer: Role of Pancreatic Stellate Cells
M. Apte (2004)
10.1007/s13193-014-0294-7
Mesopancreas in Pancreatic Cancer: Where do We Stand – Review of Literature
Ramachandra Chowdappa (2014)
10.1007/s00534-011-0466-6
Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas
Y. Nimura (2012)
10.1097/00000658-199810000-00007
Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.
S. Pedrazzoli (1998)
10.1245/s10434-011-2110-8
Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies
A. Andriulli (2011)
10.1001/archsurg.2012.1126
Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma.
Jennifer L. Gnerlich (2012)
10.1097/MPA.0b013e31818166d2
Long-Term Survival (5-20 Years) After Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Series of 30 Patients Collected From 3 Institutions
M. Adham (2008)
10.1016/J.SURG.2005.06.044
A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.
M. Farnell (2005)
10.1002/jso.24204
Top-down approach to the superior mesenteric artery and the mesopancreas during pancreatoduodenectomy for pancreatic cancer.
T. Welsch (2016)
10.1016/j.gassur.2005.05.001
Pancreaticoduodenectomy: Superior mesenteric artery first approach
P. Pessaux (2007)
10.1007/s00423-010-0663-9
Uncinate process first—a novel approach for pancreatic head resection
T. Hackert (2010)
10.2741/2880
Carcinomas of the ventral and dorsal pancreas exhibit different patterns of lymphatic spread.
H. Kitagawa (2008)
10.1016/S1072-7515(01)00856-0
Fundamentals of contemporary surgical oncology: biologic principles and the threshold concept govern treatment and outcomes.
B. Cady (2001)
10.1007/s11605-015-2882-4
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors
Salvatore Paiella (2015)
10.1097/00000658-199203000-00006
Preoperative Indications for Extended Pancreatectomy for Locally Advanced Pancreas Cancer Involving the Portal Vein
O. Ishikawa (1992)
10.1245/s10434-011-2045-0
Outcomes After Robot-Assisted Pancreaticoduodenectomy for Periampullary Lesions
H. Zeh (2011)
10.1093/ANNONC/MDS224
Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
T. Seufferlein (2012)
10.1111/j.1477-2574.2008.00013.x
Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP).
K. Menon (2009)
Extended Lymphadenectomy and "Mesopancreas" Excision during Pancreatoduodenectomy for Cancer; is it worth it? Review of Current Evidence
Elissaios Kontis (2016)
Commission on cancer oncology lectureFundamentals of contemporary surgical oncology: biologic principles and the threshold concept govern treatment and outcomes1
Blake Cady (2001)
10.1007/s11605-016-3154-7
Management of Type 9 Hepatic Arterial Anatomy at the time of Pancreaticoduodenectomy: Considerations for Preservation and Reconstruction of a Completely Replaced Common Hepatic Artery
C. Hicks (2016)
10.1016/j.suronc.2013.08.003
A systematic review on robotic pancreaticoduodenectomy.
R. Cirocchi (2013)
10.1007/s11605-013-2374-3
Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer
H. S. Tran Cao (2013)
10.1245/s10434-009-0408-6
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
M. Callery (2009)
10.1016/j.gassur.2006.08.018
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience
J. Winter (2007)
10.1016/j.surg.2014.06.016
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).
J. Tol (2014)
10.1111/hpb.12061
Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.
J. Delpero (2014)
10.1007/s11605-016-3105-3
Learning Curve for Laparoscopic Pancreaticoduodenectomy: a CUSUM Analysis
M. Wang (2016)
10.1016/j.surg.2012.05.015
R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
B. Rau (2012)
10.1097/SLA.0b013e318237872e
Correlation Between Radiographic Classification and Pathological Grade of Portal Vein Wall Invasion in Pancreatic Head Cancer
A. Nakao (2012)
10.1111/ases.12208
Major venous resection and reconstruction using a minimally invasive approach during laparoscopic pancreaticoduodenectomy: One step forward
S. Palanisamy (2015)
10.1002/bjs.7413
Systematic review and meta‐analysis of the volume–outcome relationship in pancreatic surgery
G. A. Gooiker (2011)
10.1159/000018744
A Surgical and Pathological Based Classification of Resective Treatment of Pancreatic Cancer
S. Pedrazzoli (1999)
10.1016/j.amjsurg.2008.06.035
Pancreatoduodenectomy using a no-touch isolation technique.
Masahiko Hirota (2010)
10.1371/journal.pmed.1000267
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
S. Gillen (2010)
10.1159/000227534
Extended resections of ductal pancreatic cancer--impact on operative risk and prognosis.
J. Klempnauer (1996)
10.1016/j.jamcollsurg.2014.12.052
Laparoscopic pancreaticoduodenectomy should not be routine for resection of periampullary tumors.
S. Dokmak (2015)
10.3322/caac.21332
Cancer statistics, 2016
R. Siegel (2016)
10.1097/SLA.0000000000000959
Parietal Peritoneum as an Autologous Substitute for Venous Reconstruction in Hepatopancreatobiliary Surgery.
S. Dokmak (2015)
10.1245/s10434-009-0416-6
Surgical Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement
D. Evans (2009)
10.1016/j.ejso.2012.04.007
Appraisal of a total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma.
Y. Kawabata (2012)
10.1200/JCO.2008.20.5104
Margin clearance and outcome in resected pancreatic cancer.
D. Chang (2009)
10.6092/1590-8577/3285
Left posterior approach to the superior mesenteric vascular pedicle in pancreaticoduodenectomy for cancer of the pancreatic head.
I. Kurosaki (2011)
10.1245/s10434-015-4635-8
Pancreaticoduodenectomy with Reconstruction of the Mesentericoportal Vein by the Parietal Peritoneum: ‘Safi Dokmak Vascular Graft’
S. Dokmak (2015)
10.1002/bjs.9222
Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma
P. Kim (2013)
10.1001/jama.2010.1275
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
J. Neoptolemos (2010)
10.1016/j.surg.2014.02.009
Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS).
W. Hartwig (2014)
10.1016/j.jamcollsurg.2008.04.033
Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer.
K. Bilimoria (2008)
10.1007/s11605-007-0131-1
An Innovative Option for Venous Reconstruction After Pancreaticoduodenectomy: the Left Renal Vein
R. Smoot (2007)
10.1007/s00423-009-0494-8
The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials
J. Gaedcke (2009)
10.1097/MPA.0b013e3182148342
Pattern of Lymph Node Metastasis Spread in Pancreatic Cancer
M. Kanda (2011)
10.1002/bjs.5397
Redefining the R1 resection in pancreatic cancer
C. Verbeke (2006)
10.1016/j.jamcollsurg.2015.02.019
Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer.
G. Malleo (2015)
10.1097/00000658-197707000-00007
Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection.
J. Fortner (1977)
10.1016/j.gassur.2005.09.016
Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings
S. Hishinuma (2007)
10.1245/ASO.2006.08.011
Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy
G. Varadhachary (2006)
10.1016/J.JAMCOLLSURG.2007.04.004
Laparoscopic pancreaticoduodenectomy: technique and outcomes.
C. Palanivelu (2007)
10.1007/s11605-016-3131-1
Para-Aortic Dissection in Pancreaticoduodenectomy with Mesopancreas Excision for Pancreatic Head Carcinoma: Not Only an N-Staging Matter
N Peparini (2016)
10.1097/SLA.0b013e318269d23c
Should the Portal Vein Be Routinely Resected During Pancreaticoduodenectomy For Adenocarcinoma?
O. Turrini (2013)
10.1111/j.1477-2574.2009.00110.x
Validation of a prediction rule to maximize curative (R0) resection of early-stage pancreatic adenocarcinoma.
Philip Bao (2009)
10.1002/bjs.9892
Meta‐analysis of radical resection rates and margin assessment in pancreatic cancer
M. Chandrasegaram (2015)
10.1016/J.SURG.2006.09.013
The learning curve in pancreatic surgery.
J. Tseng (2007)
10.1056/NEJMOA032295
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
J. Neoptolemos (2004)
10.1016/j.jamcollsurg.2009.10.019
The "artery first" approach for resection of pancreatic head cancer.
J. Weitz (2010)
10.1016/j.jamcollsurg.2013.09.005
Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis.
C. Correa-Gallego (2014)
10.1016/j.gassur.2006.09.001
Durability of portal venous reconstruction following resection during pancreaticoduodenectomy
R. Smoot (2007)
10.1186/1477-7819-6-123
Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery?
M. Glanemann (2008)
10.1186/1477-7819-5-44
Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space
I. Gockel (2007)
10.1097/00000658-200112000-00007
Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial
J. Neoptolemos (2001)
10.1097/00000658-199602000-00007
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
G. M. Fuhrman (1996)
10.1111/j.1477-2574.2011.00323.x
Major venous resection during total laparoscopic pancreaticoduodenectomy.
M. Kendrick (2011)
10.1016/j.amjsurg.2008.12.025
Comparison of laparoscopy-assisted and open pylorus-preserving pancreaticoduodenectomy for periampullary disease.
Akihiro Cho (2009)
10.1007/978-3-540-71279-4_10
Primary advanced unresectable pancreatic cancer.
R. Wilkowski (2008)
Extent of lymphadenectomy in the resection of pancreatic cancer. Analysis of the existing evidence.
S. Pedrazzoli (2005)
10.1016/J.SURG.2007.04.001
The learning curve in pancreatic surgery (DOI: 10.1016/j.surg.2006.09.013)
J. Tseng (2007)
10.1080/00313020802337329
Synoptic reporting improves histopathological assessment of pancreatic resection specimens
A. Gill (2009)
10.1007/s11605-013-2428-6
Optimal Management of the Splenic Vein at the Time of Venous Resection for Pancreatic Cancer: Importance of the Inferior Mesenteric Vein
Charles Henry Caldow Pilgrim (2013)
10.1016/J.ANCHIR.2005.12.006
A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma
M. Farnell (2006)
10.1007/BF00642443
Laparoscopic pylorus-preserving pancreatoduodenectomy
M. Gagner (1994)
10.1097/MD.0000000000002529
Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters
Ulrich F Wellner (2016)
10.1097/01.sla.0000259391.84304.2b
Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma
C. Raut (2007)
10.1016/j.ctrv.2015.04.013
Extent of lymphadenectomy to associate with pancreaticoduodenectomy in patients with pancreatic head cancer for better tumor staging.
S. Pedrazzoli (2015)
10.1007/s00268-014-2808-4
Resection Margin Clearance in Pancreatic Cancer After Implementation of the Leeds Pathology Protocol (LEEPP): Clinically Relevant or Just Academic?
F. Gebauer (2014)
10.1016/S1499-3872(11)60002-7
Current opinion on lymphadenectomy in pancreatic cancer surgery.
T. Pavlidis (2011)
10.1016/j.jamcollsurg.2007.12.020
Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.
M. Katz (2008)
10.1111/j.1365-2559.2009.03376.x
Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin
F. Campbell (2009)
10.1007/s00268-011-1263-8
Multivisceral Resections in Pancreatic Cancer: Identification of Risk Factors
Christoph M. Burdelski (2011)
10.1002/bjs.9135
Feasibility of robotic pancreaticoduodenectomy
U. Boggi (2013)
10.1002/bjs.5716
Systematic review and meta‐analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer
C. Michalski (2007)
10.1001/jama.2016.4324
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
P. Hammel (2016)
10.1200/JCO.2010.30.3446
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.
J. van Laethem (2010)
10.1016/S1091-255X(00)80069-4
Extent of lymphadenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas
S. Pedrazzoli (2000)
Total meso-pancreas excision: key point of resection in pancreatic head adenocarcinoma.
I. Popescu (2011)
10.1245/s10434-008-9839-8
Most Pancreatic Cancer Resections are R1 Resections
I. Esposito (2008)
10.1097/SLA.0b013e31823ac299
Arterial Resection During Pancreatectomy for Pancreatic Cancer: A Systematic Review and Meta-Analysis
N. Mollberg (2011)
10.1016/S1470-2045(15)00463-5
Justifying vein resection with pancreatoduodenectomy.
S. Barreto (2016)
10.1007/s00534-013-0614-2
Minimally invasive surgical techniques for pancreatic cancer: ready for prime time?
Marc G. Mesleh (2013)
10.1016/j.ejso.2011.12.015
Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors.
M. Adham (2012)



Semantic Scholar Logo Some data provided by SemanticScholar